The U.S. government has reached a $1.95 billion deal with Pfizer to acquire 100 million doses of its vaccine candidate against the coronavirus, if it's approved by the FDA.
Moderna and Merck declined to make this pledge. AstraZeneca said its existing deal with the federal government stipulated that it would sell 300 million doses to the government"at no profit." Johnson & Johnson said it would provide its vaccine"at a not-for-profit price during the pandemic." Pfizer did not make a similar statement in its announcement of Wednesday's deal, and Schakowsky noted that the company had previously said it would sell its vaccine for a profit.
"We recognize that these are extraordinary times, and our pricing will reflect that during the term of the pandemic," Pfizer's chief business officer John Young said during the hearing."We'll price our potential vaccine consistent with the urgent global emergency that we're facing. And secondly we also believe, and critically, that COVID vaccines should be free to the public. A vaccine is meaningless if people are unable to afford it.
He applauded the CARES Act, which he said would allow many patients to get the coronavirus vaccine with no cost-sharing."We'll see what that means," Schakowsky said.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
U.S. signs $1.95-billion deal with Pfizer for COVID-19 vaccine dosesThe U.S. has signed a contract with Pfizer for delivery in December of the first 100 million doses of a COVID-19 vaccine the company is developing.
続きを読む »
U.S. to pay Pfizer, BioNTech $1.95 billion for millions of COVID-19 vaccine dosesPfizer Inc and German biotech firm BioNTech SE will get $1.95 billion from the U.S. government to produce and deliver 100 million doses of their COVID-19 vaccine candidate, the companies said on Wednesday.
続きを読む »
U.S. government taps Pfizer to produce millions of doses of coronavirus vaccineThe vaccine is being jointly developed by German biotech firm BioNTech and U.S.-based Pfizer.
続きを読む »
Pfizer, BioNTech Get $1.95 Billion Covid-19 Vaccine Order From U.S. GovernmentPfizer and BioNTech said they have signed a $1.95 billion agreement with the U.S. Department of Health and Human Services and the Defense Department for millions of doses of a Covid-19 vaccine which Americans would receive for free.
続きを読む »
Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trialGerman biotech BioNTech and U.S. drugmaker Pfizer Inc on Monday said data from an early-stage trial of their experimental coronavirus vaccine showed that it prompted an immune response and was well-tolerated, similar to results seen in prior early test.
続きを読む »
US signs contract with Pfizer for COVID-19 vaccine dosesHealth and Human Services Secretary Alex Azar says the U.S. signed a contract with Pfizer for delivery in December of the first 100 million doses of a COVID-19 vaccine the pharmaceutical company is working to develop.
続きを読む »